ClinicalTrials.Veeva

Menu

Protein-rich Diet and NAFLD in Bariatric Surgery

C

Catholic University of the Sacred Heart

Status

Unknown

Conditions

Obesity
Non-alcoholic Fatty Liver Disease

Treatments

Other: Body composition
Other: Anthropometrical measurements
Dietary Supplement: Control low calorie diet
Other: 8-h metabolic profile
Other: Liver biopsy
Dietary Supplement: High-protein low calorie diet

Study type

Interventional

Funder types

Other

Identifiers

NCT02400099
UCSC-2015

Details and patient eligibility

About

Randomized, single-blind, trial to determine whether a high-protein, low calorie diet is more effective than a control low calorie diet in improving the metabolic and histologic abnormalities in patients with Non-alcoholic Fatty Liver Disease undergoing bariatric surgery.

Enrollment

60 estimated patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Morbidly obese subjects with a BMI >40 kg/m2 who are eligible for bariatric surgery and have accepted to undergo RYGB
  • Weight stable for at least 6 months before the study (+/- 5 kg within the previous 6 months)
  • Stable medication
  • Provision of informed consent

Exclusion criteria

  • Patients not eligible for laparoscopic RYGB
  • Incapacity to give a valid informed consent or unwilling to give the consent
  • Pregnancy or lactating
  • Type 2-diabetes mellitus
  • Significant illness within the two weeks preceding surgery, as judged by the physician.
  • Obvious infection (bacteria, virus etc)
  • Major cardiovascular disease
  • Major gastrointestinal, respiratory, or any hormonal disorders
  • History of drug addiction and/or alcohol use
  • Suspected or confirmed poor compliance
  • Alcohol consumption of > 20 g per day in the case of women and > 30 g per day in the case of men for at least 3 consecutive months during the previous 5 years
  • Presence of hepatitis C or frank cirrhosis.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups, including a placebo group

High-protein low calorie diet (HPLC)
Active Comparator group
Description:
900 Kcal; Protein 90 g (39%); CHO 75 g (30%); Lipid 32 g (31%)
Treatment:
Other: Liver biopsy
Dietary Supplement: High-protein low calorie diet
Other: 8-h metabolic profile
Other: Body composition
Other: Anthropometrical measurements
Control low calorie diet (CLC)
Placebo Comparator group
Description:
900 Kcal; Protein. 50 g (22%); CHO 119 g (48%); Lipid 31 g (30%)
Treatment:
Other: Liver biopsy
Other: 8-h metabolic profile
Dietary Supplement: Control low calorie diet
Other: Body composition
Other: Anthropometrical measurements

Trial contacts and locations

1

Loading...

Central trial contact

Geltrude Mingrone, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems